New pain treatment tested in humans

Nerve growth factor signals through receptors of the tropomyosin-related kinase (Trk) family, and research in animals has shown that inhibitors of Trks A, B, and C can reduce pain. Now a new study provides the first demonstration of pain relief in humans using a Trk inhibitor.